Ganot Ilan 4

What Happened
Ilan Ganot, a director of Solid Biosciences Inc. (SLDB), was granted a derivative award of options covering 77,500 shares on June 10, 2026. The grant is reported at $0.00 (no cash paid at grant); this filing documents an award of rights to acquire shares rather than an immediate stock purchase.

Key Details

• Transaction date: June 10, 2026; Form 4 filed June 11, 2026 (timely filing).
• Transaction type: Award/Grant (derivative option) — 77,500 underlying shares; reported price $0.00.
• Shares owned after transaction: Not specified in the filing.
• Footnote: The option vests in full on the earlier of the one‑year anniversary of the grant date and immediately prior to the issuer's next annual meeting after the grant date; it will also vest fully upon specified change‑in‑control events.
• No indication of an immediate exercise or sale; this is a compensation grant to a director.

Context
This is a standard equity compensation grant to a board member. Such option awards do not involve immediate cash or share transfers and do not, by themselves, indicate buying or selling interest in the open market. Vesting and any future exercise could result in share acquisition later, subject to the stated vesting and any exercise terms.